Podcast
Ronan O’Hagan, Chief Executive Officer
Episode 3 of BioByteas by Windsor Bux welcomes Ronan O’Hagan, Chief Executive Officer.
Ronan O’Hagan, CEO and President of Bectas Therapeutics, shares his insights and experiences in the biotech industry. He discusses his career moves and the importance of building teams and organizations. Ronan emphasizes the value of leadership skills and aligning personal and company values. He also provides advice for leaders in biotech and discusses fostering a culture of innovation and collaboration within organizations. Ronan also shares lessons learned from setbacks, emphasizing the importance of transparent communication, taking responsibility, and learning from failures. Finally, Ronan offers advice for emerging biotech leaders on navigating the challenges of scaling their companies and attracting investment.
Takeaways
- Align rewards and recognition with the values of the organization to avoid rewarding misaligned behaviors.
- Transparent communication, taking responsibility, and learning from setbacks are crucial for growth and development.
- Building and maintaining strong relationships with key stakeholders requires effective communication and early engagement.
- Make decisions quickly, relying on a balance of information and experience, while staying focused on the mission of serving patients.
You can also listen to this podcast on Spotifty:
Welcome to BioBytes – Windsor Bux, where we bring you exclusive interviews with the movers and shakers of the biotech and pharmaceutical industry. Join us as we delve into the experiences and valuable insights of leading executives, exploring how they’re shaping the future and making a difference. Get ready for compelling conversations that will expand your knowledge and inspire your own journey in this exciting field!
- Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics
- Sandy Milligan, MD JD, C-Suite Executive & Board Member
- Alex Oshmyansky, MD, PhD, CEO / Co-Founder
- Derek Adams, CEO & President
- Jason Cole – CEO & Chair of the Board, SalioGen
- David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund
- Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund
- Ronan O’Hagan, Chief Executive Officer
- Alison Schecter, MD, CMO/CEO
- Joe Foster – Reebok, Founder